ArticleBMJ open2021

CBmeter study: protocol for assessing the predictive value of peripheral chemoreceptor overactivation for metabolic diseases.

Marlene Lages et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.